Page last updated: 2024-11-08

dentatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dentatin: from Clausena excavata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
ClausenagenusA plant genus of the family RUTACEAE. Members contain anethole and CARBAZOLES.[MeSH]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID342801
CHEMBL ID552132
CHEBI ID69939
MeSH IDM0585466

Synonyms (23)

Synonym
nsc-380684
22980-57-0
nsc380684
10-(1,1-dimethyl-allyl)-5-methoxy-8,8-dimethyl-8h-pyrano[3,2-g]chromen-2-one
dentatin
10-(1,1-dimethylallyl)-5-methoxy-2,2-dimethyl-pyrano[3,2-g]chromen-8-one
poncitrin
chebi:69939 ,
CHEMBL552132
5-methoxy-2,2-dimethyl-10-(2-methylbut-3-en-2-yl)pyrano[3,2-g]chromen-8-one
10-(1,1-dimethyl-allyl)-5-methoxy-8,8-dimethyl-8h-pyrano(3,2-g)chromen-2-one
nsc 380684
2h,8h-benzo[1,2-b:5,4-b']dipyran-2-one, 5-methoxy-8,8-dimethyl-10-(1,1-dimethyl-2-propenyl)
QBFYQVZGIDUNIY-UHFFFAOYSA-N
DTXSID80177527
8,8-dimethyl-10-(1,1-dimethyl-2-propenyl)-5-methoxy-2h,8h-benzo[1,2-b:5,4-b']dipyran-2-one
Q27138282
QS6H8T54ZE
2h,8h-benzo[1,2-b:5,4-b']dipyran-2-one, 10-(1,1-dimethylallyl)-5-methoxy-8,8-dimethyl-
2h,8h-benzo[1,2-b:5,4-b']dipyran-2-one, 10-(1,1-dimethyl-2-propen-1-yl)-5-methoxy-8,8-dimethyl-
5-methoxy-8,8-dimethyl-10-(2-methylbut-3-en-2-yl)-2h,8h-pyrano[3,2-g]chromen-2-one
10-(1,1-dimethyl-2-propen-1-yl)-5-methoxy-8,8-dimethyl-2h,8h-benzo[1,2-b:5,4-b']dipyran-2-one
AKOS040735267

Research Excerpts

Overview

Dentatin may prove to be an essential lead molecule for the management of colon cancer.

ExcerptReferenceRelevance
"Dentatin may prove to be an essential lead molecule for the management of colon cancer."( Dentatin exerts anticancer effects on human colon cancer cell lines via cell cycle arrest, autophagy, inhibition of cell migration and JAK/STAT signalling pathway.
Dong, J; Kong, S; Xiong, W,
)
3.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
coumarins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID431554Cytotoxicity against human MCF7 cells after 3 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
AID431551Antiviral activity against Hepatitis B virus infected in human Hep2A cells assessed as suppression of viral surface antigen production after 48 hrs by enzyme immunoassay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
AID431553Cytotoxicity against human A549 cells after 3 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
AID1234147Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by Alamar Blue staining-based broth microdilution assay2015European journal of medicinal chemistry, Jul-15, Volume: 100Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
AID587892Cytotoxicity against human KB cells by resazurin microplate assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Claurailas A-D, cytotoxic carbazole alkaloids from the roots of Clausena harmandiana.
AID431555Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
AID492425Antimalarial activity against Plasmodium falciparum2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID587894Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Claurailas A-D, cytotoxic carbazole alkaloids from the roots of Clausena harmandiana.
AID587893Cytotoxicity against human NCI-H187 by resazurin microplate assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Claurailas A-D, cytotoxic carbazole alkaloids from the roots of Clausena harmandiana.
AID431556Cytotoxicity against human KBVIN cells after 3 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]